BenevolentAI

Drug Discovery · Drug Discovery AI
Data updated Nov 22, 2026Money ledger: 7 records from 1 sourceFiled 7Full reportReport a mistake

Facts

as of Nov 22, 2026

BenevolentAI is a British company founded in London in 2013 that applies machine learning to drug discovery, building a knowledge graph from scientific literature, clinical data and experimental results to propose new targets and treatments. Its best known result came in 2020, when the platform identified the arthritis drug baricitinib as a potential COVID-19 therapy, a hypothesis later confirmed in trials and approved by regulators. The company listed on Euronext Amsterdam in 2022, delisted in 2024 after restructuring and heavy cost reductions, and now runs a narrower pipeline alongside partnerships with pharmaceutical companies including AstraZeneca and Merck.

Legal name
BENEVOLENTAI LIMITEDactive
Headquarters
London, United Kingdom
Founded
2013
Employees
51-200estimated range
Register numbers
CRN 09781806

These are the key facts about BenevolentAI on Alion as of Nov 22, 2026. BenevolentAI is headquartered in London, United Kingdom. It was founded in 2013.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

BenevolentAI: 7 money records, each linked to its source.

7Rounds and grants3 investors
Money innewest first
Equity raised
Apr 2022 · Venture round
not statedPaid
Equity raised
Feb 2021 · Venture round
not statedPaid
Equity raised
Dec 2019 · Venture round
not statedPaid
4 more records: amounts, dates and sources of every round, loan and commitmentProUnlockor this company alone for 30 days · 50 credits
Money by yearUSD, rounds and grants
2022-1 record
2021-1 record
2019-3 records
2018-1 record
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Products

Products →

BenevolentAI names 4 products on its own site.

top 0.05%Web presenceof 133.2M domains by links, Common Crawl
Products named on its site
Benevolent Platform
The Benevolent Platform combines a biomedical knowledge graph with machine learning to generate and rank drug…
Benevolent Knowledge Graph
The knowledge graph structures relationships between genes, diseases, compounds and pathways extracted from s…
Target Identification
The target identification service proposes and prioritises novel biological targets for a given disease. It i…
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.

BenevolentAI: 62 research papers in five years.

Legal entity active
BENEVOLENTAI LIMITED
Yes
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Milestones
Raised a round Venture round
Apr 22, 2022
Raised a round SPAC $225M
2022
Incorporated BENEVOLENTAI LIMITED · Companies House
Sep 17, 2015
Founded
2013
Sources: the outlets named on each headline, each story once

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
London United KingdomHeadquarters0
Source: office addresses in postings and company registers